Write it directly on the label with a permanent marker so you never lose track of the 28-day window
Most patients experience mild symptoms that can include nausea or stomach discomfort, particularly during initial doses
It was more like waves of nausea that lasted 15-30 seconds, maybe once a day, sometimes more
Managing side effects during dose escalation Nearly every semaglutide user experiences some gastrointestinal side effects, particularly during dose increases
Thus, while it is conceivable yet not statistically confirmed that semaglutide could cause AKI in selected patients, there is plenty of evidence that it reduces nephropathy in the long term
GLP-1 receptor agonists (semaglutide, liraglutide, tirzepatide) do not list infertility as a recognised adverse effect in MHRA-approved product information